semaglutide puerto rico leads U.S. growth in GLP-1 prescriptions in 2025 Semaglutide injections for weight loss
Description
In addition to other medicinal products for the treatment of diabetes
Reddys Laboratories has launched Obeda, an injectable semaglutide therapy for diabetes and weight management in India.
A new study shows that more Americans are choosing GLP-1 medications over bariatric surgery, but insurance coverage in Louisiana complicates that choice.
The GLP-1 market is projected to exceed 100B USD by 2030
With the use of semaglutide as a treatment for weight loss, it's crucial to understand the strategies and lifestyle changes that can help individuals in their long-term weight sustainability.
